Hunan Jiudian Pharmaceutical Co., Ltd.
SZSE:300705.SZ
24.47 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 443.307 | 425.048 | 345.843 | 398.405 | 135.258 | 131.578 | 170.556 | 298.429 | 70.799 | 33.965 | 27.85 | 42.981 |
| Short Term Investments
| 260.71 | 90.291 | 90.256 | 100.314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 704.018 | 515.34 | 436.099 | 498.72 | 135.258 | 131.578 | 170.556 | 298.429 | 70.799 | 33.965 | 27.85 | 42.981 |
| Net Receivables
| 476.795 | 625.761 | 503.58 | 284.896 | 189.496 | 148.995 | 154.288 | 119.328 | 74.899 | 65.598 | 51.333 | 43.01 |
| Inventory
| 367.705 | 265.529 | 241.039 | 214.479 | 153.118 | 136.398 | 109.231 | 95.88 | 77.578 | 63.865 | 55.537 | 52.417 |
| Other Current Assets
| 53.257 | 23.329 | 25.776 | 22.178 | 25.733 | 37.207 | 31.84 | 5.056 | 11.331 | 17.512 | 11.186 | 6.157 |
| Total Current Assets
| 1,601.775 | 1,429.958 | 1,206.495 | 1,020.272 | 503.604 | 454.178 | 465.915 | 518.693 | 234.607 | 180.941 | 145.907 | 144.564 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,354.66 | 1,216.125 | 892.285 | 606.828 | 533.149 | 535.637 | 404.555 | 173.761 | 137.818 | 112.398 | 97.195 | 80.447 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 150.107 | 112.232 | 100.266 | 77.355 | 51.062 | 52.141 | 52.865 | 52.045 | 17.436 | 19.688 | 21.612 | 23.987 |
| Goodwill and Intangible Assets
| 150.107 | 112.232 | 100.266 | 77.355 | 51.062 | 52.141 | 52.865 | 52.045 | 17.436 | 19.688 | 21.612 | 23.987 |
| Long Term Investments
| -138.423 | 30 | -60.256 | 5.788 | 6.776 | 3.434 | 0.401 | 0.604 | 0.65 | 0.747 | 1.29 | 1.6 |
| Tax Assets
| 49.515 | 66.295 | 43.213 | 29.193 | 17.851 | 14.861 | 5.93 | 7.941 | 0.789 | 0.815 | 0.826 | 0.974 |
| Other Non-Current Assets
| 355.498 | 16.59 | 117.668 | 5.801 | 18.279 | 11.847 | 13.545 | 16.158 | 5.733 | 3.73 | 1.743 | 0.578 |
| Total Non-Current Assets
| 1,771.357 | 1,441.242 | 1,093.177 | 724.965 | 627.116 | 617.921 | 477.296 | 250.51 | 162.425 | 137.379 | 122.667 | 107.587 |
| Total Assets
| 3,373.131 | 2,871.2 | 2,299.671 | 1,745.237 | 1,130.72 | 1,072.099 | 943.211 | 769.203 | 397.033 | 318.32 | 268.573 | 252.151 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 126.386 | 159.295 | 143.796 | 108.877 | 59.907 | 69.351 | 54.714 | 32.613 | 30.195 | 23.676 | 20.19 | 15.565 |
| Short Term Debt
| 0 | 51.847 | 71.568 | 53.766 | 10.4 | 71.434 | 50 | 4 | 20 | 20 | 15 | 30 |
| Tax Payables
| 26.778 | 8.916 | 23.932 | 27.471 | 17.315 | 10.799 | 14.424 | 14.452 | 3.785 | 1.027 | 2.791 | 1.506 |
| Deferred Revenue
| 0 | 0 | 195.577 | 147.082 | 94.338 | 43.253 | 36.388 | 31.291 | 14.282 | 11.189 | 15.468 | 16.96 |
| Other Current Liabilities
| 238.699 | 195.503 | 132.8 | 122.849 | 51.182 | 5.706 | 37.994 | 16.839 | 3.959 | 6.114 | 3.336 | 11.205 |
| Total Current Liabilities
| 391.864 | 415.562 | 444.345 | 370.376 | 180.96 | 200.544 | 157.132 | 79.95 | 72.221 | 62.006 | 56.785 | 73.155 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 293.768 | 332.528 | 231.636 | 224.276 | 70.502 | 68.723 | 29.689 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 155.952 | 145.374 | 65.523 | 51.247 | 43.576 | 40.961 | 38.23 | 28.997 | 1.384 | 1.804 | 1.922 | 3.147 |
| Deferred Tax Liabilities Non-Current
| 4.817 | 4.466 | 5.548 | -0 | -43.576 | -68.723 | -29.689 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.039 | 0 | 0 | 0 | 38.23 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 454.538 | 482.368 | 302.706 | 275.523 | 114.078 | 109.684 | 67.919 | 28.997 | 1.384 | 1.804 | 1.922 | 3.147 |
| Total Liabilities
| 846.401 | 897.93 | 747.05 | 645.899 | 295.038 | 310.228 | 225.052 | 108.947 | 73.605 | 63.811 | 58.707 | 76.302 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 496.194 | 345.145 | 342.936 | 234.687 | 234.68 | 234.68 | 234.68 | 117.34 | 88 | 80.58 | 47.4 | 47.4 |
| Retained Earnings
| 1,247.762 | 887.682 | 633.27 | 451.187 | 278.938 | 213.818 | 176.568 | 127.096 | 65.167 | 28.224 | 109.421 | 79.308 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 247.724 | 120.475 | 65.183 | 43.278 | 34.587 | 28.093 | 19.693 | 13.048 | 7.785 | 0 | -0 |
| Other Total Stockholders Equity
| 782.774 | 492.718 | 455.94 | 413.463 | 278.786 | 278.786 | 307.203 | 415.819 | 157.213 | 145.705 | 38.8 | 49.23 |
| Total Shareholders Equity
| 2,526.73 | 1,973.27 | 1,552.621 | 1,099.338 | 835.682 | 761.871 | 718.159 | 660.255 | 323.428 | 254.509 | 209.866 | 175.938 |
| Total Equity
| 2,526.73 | 1,973.27 | 1,552.621 | 1,099.338 | 835.682 | 761.871 | 718.159 | 660.255 | 323.428 | 254.509 | 209.866 | 175.849 |
| Total Liabilities & Shareholders Equity
| 3,373.131 | 2,871.2 | 2,299.671 | 1,745.237 | 1,130.72 | 1,072.099 | 943.211 | 769.203 | 397.033 | 318.32 | 268.573 | 252.151 |